Replies to post #12724 on Moderna Inc (MRNA)

[Civil War General]

The number of patients reporting treatment related Grade = 3 adverse events were similar between the arms (25% vs 18%, respectively). The most common adverse events of any grade attributed to either mRNA-4157 (V940) or the combination of mRNA-4157 (V940) and KEYTRUDA were fatigue (60.6%), injection site pain (55.8%) and chills (50.0%).

Compared to the experience of Stage 3 Melanoma this is acceptable.